NVDA
NVIDIA Corporation
NVDA has the edge over NYAX overall, supported by stronger modeled upside and stronger valuation.
NYAX
Nayax Ltd.
NYAX's outlook is improving, though it still trails on the overall score.
NVDA Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
NVDA's revenue, profitability, cash flow and balance sheet are all currently strong.
NYAX Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Healthy | |
| Healthy |
NYAX's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
NVDA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $166 | — |
| Current | 21x | $166 | — |
| Cheap | 44x | $345 | +108% |
| Fair | 65x | $511 | +207% |
| Expensive | 93x | $734 | +342% |
Historical ranges are pointers, not guarantees.
NVDA has the edge over NYAX in the historical PE scenario, which offers more potential upside but is not a forecast.
NYAX PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 48x | $52.18 | — |
| Cheap | 66x | $13.83 | -73% |
| Fair | 82x | $17.22 | -67% |
| Expensive | 228x | $47.78 | -8.4% |
| Current | 246x | $52.18 | — |
Historical ranges are pointers, not guarantees.
NYAX's PE is in its expensive range at 246x. If earnings grow as analysts expect, today's price would be 48x next year's earnings, in its cheap range.
NVDA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Weakening | |
| Broad | |
| Moderate |
Analysts expect strong earnings and revenue growth for NVDA, but weaker profitability.
NYAX Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
NYAX has the edge over NVDA on the outlook, with more favorable profitability expectations.
NVDA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.77 | +74% |
| Q3 2026 | $7.91 | +125% |
| Q2 2026 | $6.53 | +111% |
| Q1 2026 | $4.90 | +67% |
| Q4 2025 | $4.03 | +59% |
| Q3 2025 | $3.51 | +65% |
| Q2 2025 | $3.10 | +81% |
| Q1 2025 | $2.94 | +147% |
| Q4 2024 | $2.54 | +234% |
NVDA has the edge over NYAX on earnings, with more consistent year-over-year improvement.
NYAX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.09 | +420% |
| Q2 2026 | $0.21 | -63% |
| Q1 2026 | $0.79 | +339% |
| Q4 2025 | $0.96 | +$1.13 |
| Q3 2025 | $0.65 | +$0.96 |
| Q2 2025 | $0.57 | +$1.00 |
| Q1 2025 | $0.18 | +$0.64 |
| Q4 2024 | -$0.17 | +$0.31 |
| Q3 2024 | -$0.31 | +$0.30 |
NYAX earned $0.21 per share over the past year, down 63% from the year before.
NVDA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $96.2B | +106% |
| Q2 2026 | $81.6B | +85% |
| Q1 2026 | $68.1B | +73% |
| Q4 2025 | $57B | +62% |
| Q3 2025 | $46.7B | +56% |
| Q2 2025 | $44.1B | +69% |
| Q1 2025 | $39.3B | +78% |
| Q4 2024 | $35.1B | +94% |
NVDA has the edge over NYAX on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 66% | +5.4 points |
| Q2 2026 | 66% | +17 points |
| Q1 2026 | 65% | +3.9 points |
| Q4 2025 | 63% | +0.8 points |
| Q3 2025 | 61% | -1.2 points |
| Q2 2025 | 49% | -16 points |
| Q1 2025 | 61% | -0.5 points |
| Q4 2024 | 62% | +4.9 points |
NVDA has the edge over NYAX on profitability, with a higher operating margin.
NYAX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $122.6M | +28% |
| Q1 2026 | $105.9M | +31% |
| Q4 2025 | $121.9M | +37% |
| Q3 2025 | $105.8M | +27% |
| Q2 2025 | $95.6M | +22% |
| Q1 2025 | $81.1M | +27% |
| Q4 2024 | $89M | +27% |
| Q3 2024 | $83M | +38% |
NYAX's revenue has grown year over year every quarter since early 2021: $123M last quarter, up 28% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -5.4% | -15 points |
| Q1 2026 | 3.9% | -5.9 points |
| Q4 2025 | 11% | +6.9 points |
| Q3 2025 | 8.3% | +6.5 points |
| Q2 2025 | 10% | +8.8 points |
| Q1 2025 | 9.7% | +14 points |
| Q4 2024 | 4% | +5.9 points |
| Q3 2024 | 1.8% | +4.2 points |
NYAX's operating margin was −5.4% last quarter, down 15 points from the same quarter a year ago.
NVDA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $21.4B | +59% |
| Q2 2026 | $48.6B | +86% |
| Q1 2026 | $34.9B | +124% |
| Q4 2025 | $22.1B | +32% |
| Q3 2025 | $13.5B | -0.3% |
| Q2 2025 | $26.2B | +75% |
| Q1 2025 | $15.6B | +38% |
| Q3 2024 | $13.5B | +113% |
NVDA has the edge over NYAX on cash flow, with more consistent year-over-year improvement.
NYAX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.7M | -167% |
| Q1 2026 | $977.3K | +$6.7M |
| Q4 2025 | $16.3M | +76% |
| Q3 2025 | $15.5M | +53% |
| Q2 2025 | $5.6M | +91% |
| Q1 2025 | -$5.7M | -$1.3M |
| Q4 2024 | $9.3M | +$10.8M |
| Q3 2024 | $10.1M | +1431% |
NYAX usually generates cash, though not every quarter: the latest was −$4M, but it generated $29M over the past year.
NVDA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -106M shares |
| 1 year | -1% | -247M shares |
| 3 years | -2.8% | -705M shares |
| 5 years | -4.1% | -1B shares |
| Available history | -1.8% | -435M shares |
NVDA has the edge over NYAX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $19.7B |
| Q2 2026 | $19.3B |
| Q1 2026 | $3.8B |
| Q4 2025 | $12.5B |
| Q3 2025 | $9.7B |
| Q2 2025 | $14.1B |
| Q1 2025 | $7.8B |
| Q4 2024 | $11B |
NVDA spent $55.3B buying back its own shares over the past year, up 30% from the year before.
NYAX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -9.6% | -4M shares |
| 1 year | -0.6% | -211K shares |
| 3 years | +14% | +4.6M shares |
| 5 years | +23% | +7.1M shares |
| Available history | +51% | +12.7M shares |
NYAX has 38M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NYAX hasn't bought back shares in the past year.
NVDA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | -0.0x | Net Cash |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.0x | Net Cash |
| Q3 2025 | -0.0x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.0x | Very low |
| Q4 2024 | -0.0x | Net Cash |
NVDA has the edge over NYAX on leverage, with a lower net debt burden relative to earnings.
NYAX Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.0x | Healthy |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.0x | Net Cash |
| Q3 2025 | -1.5x | Net Cash |
| Q2 2025 | -0.2x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -1.1x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
NYAX's net debt is about a year of its operating earnings (EBITDA), after holding more cash than debt a year ago.
NVDA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.4 | Neutral |
| Stochastic | 18.1 | Oversold |
NVDA's weekly RSI is 33 (neutral) and its Stochastic is 18 (oversold).
NYAX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 48.5 | Neutral |
| Stochastic | 28.3 | Neutral |
NYAX's weekly RSI is 48 (neutral) and its Stochastic is 28 (neutral).
NVDA PE vs Technology Sector
| Metric | NVDA | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 28x | 25% below |
| PE % | 0 | 35 | 35 pts below |
NVDA has the edge over NYAX on valuation relative to its sector.
NYAX PE vs Technology Sector
| Metric | NYAX | Sector median | Relative |
|---|---|---|---|
| PE | 246x | 28x | 781% above |
| PE % | 91 | 40 | 51 pts above |
NYAX is trading at 246x earnings, a 781% premium to the Technology sector's median of 28x.
NVDA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $208.9 | 20% below |
| 20 week MA | $212.0 | 22% below |
| 50 week MA | $199.9 | 17% below |
| 100 week MA | $175.1 | 5.1% below |
| 200 week MA | $123.6 | 34% above |
NVDA has fallen below most of its moving averages, though it's still 34% above its 200-week average.
NYAX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.7 | 9.3% above |
| 20 week MA | $54.0 | 3.4% below |
| 50 week MA | $57.2 | 8.8% below |
| 100 week MA | $49.3 | 5.8% above |
| 200 week MA | $36.0 | 45% above |
NYAX has the edge over NVDA on trend strength, trading above more of its moving averages.
NVDA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.92 | $13.0 | +119% |
| 2021 | $13.0 | $29.6 | +128% |
| 2022 | $29.6 | $15.2 | -49% |
| 2023 | $15.2 | $49.5 | +226% |
| 2024 | $49.5 | $137.0 | +177% |
| 2025 | $137.0 | $190.5 | +39% |
| 2026 YTD | $190.5 | $166.2 | -13% |
NVDA's yearly returns have swung widely, from +226% in 2023 to −49% in 2022. It's down 13% so far in 2026.
NYAX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2022 | $26.5 | $19.7 | -26% |
| 2023 | $19.7 | $19.1 | -3.3% |
| 2024 | $19.1 | $27.8 | +46% |
| 2025 | $27.8 | $48.3 | +74% |
| 2026 YTD | $48.3 | $52.2 | +8% |
NYAX has the edge over NVDA on returns for 2026, with the stronger performance.